Is Molina Healthcare Stock Underperforming the Nasdaq?

Core Insights - Molina Healthcare, Inc. is a significant player in the managed healthcare services sector, focusing on low-income families and individuals through Medicaid and Medicare programs, with a market cap of $9.6 billion [1][2] Financial Performance - Molina's stock has experienced a significant decline, dropping 50.1% from its 52-week high of $359.97 on April 4, and 39.2% over the past three months, underperforming the Nasdaq Composite's 15% increase during the same period [3] - Year-to-date, Molina's stock is down 38.3%, and it has decreased 49.4% over the past 52 weeks, contrasting with the Nasdaq's 16.4% rise in 2025 and 27.9% increase over the past year [4] - Following the release of mixed Q2 results on July 23, Molina's stock plummeted 16.8%, despite premium collections rising 15.1% year-over-year, leading to a topline of $11.4 billion, which was up 15.7% year-over-year and 5.4% above expectations [5] - The company's adjusted EPS fell by 6.5% to $5.48, missing consensus estimates due to rising medical costs, prompting a reduction in the full-year outlook [6] Competitive Position - Compared to its peer Centene Corporation, Molina has fared better, with Centene experiencing a 46.9% decline in 2025 and a 57.9% drop over the past 52 weeks [6]